Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to study the effects of an experimental (not Food and Drug Administration (FDA)-approved) treatment called corneal crosslinking (CXL) for conditions in which the cor...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Woolfson Eye Institute
NCT07400952 · Keratoconus
NCT07372911 · Keratoconus
NCT06451718 · Keratoconus
NCT07213063 · Down Syndrome (DS), Supplementation
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
Woolfson Eye Institute
Atlanta, Georgia
Woolfson Eye Institute
Atlanta, Georgia
Woolfson Eye Institute
Canton, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions